Is It Inflammatory Bowel Disease Flare or Pediatric Inflammatory Multisystem Syndrome Temporally Associated with

Paulina Krawiec1, Violetta Opoka-Winiarska2, Elżbieta Pac-Kożuchowska1

  • 1Department of Pediatrics and Gastroenterology, Medical University of Lublin, Racławickie 1, 20-059 Lublin, Poland.

Insights

Pediatric inflammatory multisystem syndrome (PIMS-TS/MIS-C) can mimic inflammatory bowel disease (IBD) flares in children. Differentiating these conditions presents significant diagnostic and treatment challenges due to overlapping gastrointestinal symptoms.

Area of Science:

  • Pediatric rheumatology
  • Pediatric gastroenterology
  • Infectious diseases

Background:

  • Pediatric inflammatory multisystem syndrome temporally associated with COVID-19/multi-system inflammatory syndrome in children (PIMS-TS/MIS-C) is a severe complication of SARS-CoV-2 infection.
  • Gastrointestinal symptoms are common in PIMS-TS/MIS-C, complicating diagnosis in children with existing inflammatory bowel disease (IBD).

Purpose of the Study:

  • To describe clinical features and diagnostic/therapeutic challenges in children with overlapping IBD and PIMS-TS/MIS-C.
  • To analyze the interplay between IBD exacerbations and PIMS-TS/MIS-C in a pediatric population.

Main Methods:

  • Retrospective review of medical records of children hospitalized with overlapping IBD and PIMS-TS/MIS-C.
  • Study conducted at a single pediatric hospital between December 2020 and December 2021.

Main Results:

  • Four children with concurrent IBD flare and PIMS-TS/MIS-C were identified.
  • PIMS-TS/MIS-C onset occurred during IBD therapy in most cases, with all presenting with gastrointestinal symptoms.
  • Treatment included IVIG, ASA, and steroids in most cases; one child was vaccinated.

Conclusions:

  • SARS-CoV-2 infection can trigger PIMS-TS/MIS-C in children with IBD, potentially exacerbating the underlying condition.
  • The clinical similarity between PIMS-TS/MIS-C and IBD flares poses significant diagnostic and therapeutic hurdles.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
409
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
547
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
351
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
434
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
206
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
257